Stay updated on NYX-2925 Efficacy & Safety in DPN Clinical Trial

Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NYX-2925 Efficacy & Safety in DPN Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page history.
    Difference
    0.0%
    Check dated 2026-03-11T10:55:06.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page shows a new site revision banner (v3.4.2) and removes an outdated funding-status notice (v3.4.1); these are minor UI updates that do not alter the study information.
    Difference
    0.3%
    Check dated 2026-02-11T02:08:08.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T00:26:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Minor UI and copy updates: shows a glossary toggle, capitalization tweaks (No FEAR Act Data; Last Update Submitted that Met QC Criteria), and a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T22:43:25.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no visible changes to the page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:24:43.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites across AZ, CA, CT, FL, GA, ID, IL, MO, NJ, NY, OH, TN, TX, and VA, and removed several state-specific location subsections and the HHS Vulnerability Disclosure.
    Difference
    1%
    Check dated 2025-12-23T09:45:16.000Z thumbnail image

Stay in the know with updates to NYX-2925 Efficacy & Safety in DPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.